February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Feb. 2026Pharmacy Updates

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted. 

To avoid denials at the pharmacy, prescribers are encouraged to begin transitioning current Pulmicort Flexhaler patients to covered alternatives as soon as possible.

Preferred/Covered PDL alternatives for Pulmicort Flexhaler include the following*:

  • Arnuity Ellipta
  • Asmanex HFA
  • Asmanex Twisthaler
  • Budesonide 0.25 mg/2 mL and 0.5 mg/2 mL Respules
  • Qvar Redihaler
  • Fluticasone Propionate HFA for patients < 19 years old

Recent Announcements

CME/CEU Webinar: Bright Beginnings: The Role of Medical and Dental Providers in Early Oral Health

Please join us for a live, CME-accredited and CEU-accredited webinar on Monday, Aug. 24 from noon to 1 p.m., that will educate providers on the importance of early childhood oral health.
Jun. 2026Education/Webinars

Voluntary nationwide recall: Dexcom G7 sensors (June 2026)

Dexcom, Inc. is recalling two lots of Dexcom G7 sensors. Dexcom G7 sensors are used to monitor blood glucose levels as part of the Dexcom Glucose Monitoring system.
Jun. 2026Pharmacy Updates

Provider OnLine Multi-Factor Authentication Enhancements coming soon

Microsoft changes and security enhancements will soon require Provider OnLine users to complete multi-factor authentication (MFA) each time they log in to access the portal. MFA is a security feature that adds an extra layer of protection by requiring more than just a password. This MFA requirement is expected to take effect on June 25, 2026.
Jun. 2026Important Notices